Condition: Colitis, Ulcerative · Crohn Disease · Sponsor: Eli Lilly and Company
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of new treatments in adults with moderately to severely active ulcerative colitis or Crohn's disease and will last at least 62 weeks.
This description comes directly from the study's public registry record.
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Arizona - Scottsdale | Scottsdale, Arizona, United States | Not Yet Recruiting |
| Biopharma Informatic, LLC | Los Angeles, California, United States | Recruiting |
| Om Research LLC | Oxnard, California, United States | Recruiting |
| South Denver Gastroenterology | Englewood, Colorado, United States | Recruiting |
| Gastro Health Research - Miami | Miami, Florida, United States | Not Yet Recruiting |
| Ezy Medical Research | Miami Lakes, Florida, United States | Recruiting |
| Atlanta Gastroenterology Associates - Peachtree Dunwoody | Atlanta, Georgia, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Not Yet Recruiting |
| Cotton O'Neil Digestive Health Center | Topeka, Kansas, United States | Recruiting |
| Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center | Wyoming, Michigan, United States | Recruiting |
| KAD Clinical Research | St Louis, Missouri, United States | Not Yet Recruiting |
| Vector Clinical Trials | Las Vegas, Nevada, United States | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07483073